Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TYR | P14679 | 1/20 | 0.75 |
| ▸ | SLC5A1 | P13866 | 1/20 | 0.67 |
| ▸ | SLC5A2 | P31639 | 1/20 | 0.67 |
| ▸ | NPC1 | O15118 | 2/20 | 0.62 |
| ▸ | RAB9A | P51151 | 2/20 | 0.62 |
| ▸ | IL2 | P60568 | 1/20 | 0.60 |
| ▸ | POLB | P06746 | 1/20 | 0.59 |
| ▸ | ACHE | P22303 | 1/20 | 0.59 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4187277 | 1.00 | TYR (0.75) | TYRSLC5A1SLC5A2NPC1RAB9A | |
| SCHEMBL4187272 | 1.00 | TYR (0.75) | TYRSLC5A1SLC5A2NPC1RAB9A | |
| SCHEMBL15533442 | 1.00 | TYR (0.75) | TYRSLC5A1SLC5A2NPC1RAB9A | |
| SCHEMBL7744552 | 1.00 | TYR (0.75) | TYRSLC5A1SLC5A2NPC1RAB9A | |
| SCHEMBL18022555 | 1.00 | TYR (0.75) | TYRSLC5A1SLC5A2NPC1RAB9A | |
| SCHEMBL8388035 | 1.00 | TYR (0.75) | TYRSLC5A1SLC5A2NPC1RAB9A | |
| SCHEMBL16689576 | 1.00 | TYR (0.75) | TYRSLC5A1SLC5A2NPC1RAB9A | |
| SCHEMBL17623940 | 1.00 | TYR (0.75) | TYRSLC5A1SLC5A2NPC1RAB9A | |
| SCHEMBL15589634 | 1.00 | TYR (0.75) | TYRSLC5A1SLC5A2NPC1RAB9A | |
| SCHEMBL16785939 | 1.00 | TYR (0.75) | TYRSLC5A1SLC5A2NPC1RAB9A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 40 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118649173-A | Application of glycoside compound | 深圳大学 | 2024-09-17 | — | — | CN | disclosed |
| CN-107428665-B | Method for producing (meth) acrylic ester | 东亚合成株式会社 | 2021-10-15 | — | — | CN | disclosed |
| CN-107406363-B | Method for producing (meth) acrylic ester | 东亚合成株式会社 | 2021-10-08 | — | — | CN | disclosed |
| CN-105683389-B | Method for specifically labeling live bacteria comprising use of modified monosaccharide compounds | 国家科学研究中心 | 2021-09-28 | — | — | CN | disclosed |
| CN-107709377-B | Curable composition | 东亚合成株式会社 | 2021-04-20 | — | — | CN | disclosed |
| EP-3063288-B1 | A METHOD FOR LABELING SPECIFICALLY LIVING BACTERIA COMPRISING THE USE OF MODIFIED MONOSACCHARIDE COMPOUNDS | CENTRE NAT RECH SCIENT (FR) | 2020-12-02 | — | — | EP | disclosed |
| CN-107709376-B | Curable composition | 东亚合成株式会社 | 2020-10-30 | — | — | CN | disclosed |
| CN-107922555-B | Curable composition | 东亚合成株式会社 | 2020-08-28 | — | — | CN | disclosed |
| EP-3281933-B1 | (METH)ACRYLATE MANUFACTURING METHOD | TOAGOSEI CO LTD (JP) | 2020-08-19 | — | — | EP | disclosed |
| US-10619058-B2 | Curable composition | TOAGOSEI CO., LTD. (JP) | 2020-04-14 | — | — | US | disclosed |
| US-20170204044-A1 | MULTIFUNCTIONAL (METH)ACRYLATE MANUFACTURING METHOD | TOAGOSEI CO., LTD. (JP) | 2017-07-20 | — | — | US | disclosed |
| WO-2017079456-A1 | SYNTHETIC ANTIGEN CONSTRUCTS AGAINST CAMPYLOBACTER JEJUNI | THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF THE NAVY (US) | 2017-05-11 | — | — | WO | disclosed |
| EP-3133058-A1 | MULTIFUNCTIONAL (METH)ACRYLATE MANUFACTURING METHOD | Toagosei Co., Ltd. (JP) | 2017-02-22 | — | — | EP | disclosed |
| CN-106029628-A | Multifunctional (meth)acrylate manufacturing method | 东亚合成株式会社 | 2016-10-12 | — | — | CN | disclosed |
| EP-3063288-A1 | A METHOD FOR LABELING SPECIFICALLY LIVING BACTERIA COMPRISING THE USE OF MODIFIED MONOSACCHARIDE COMPOUNDS | Centre National de la Recherche Scientifique (C.N.R.S.) (FR) | 2016-09-07 | — | — | EP | disclosed |
| US-20160238609-A1 | A METHOD FOR LABELING SPECIFICALLY LIVING AND BACTERIA COMPRISING THE USE OF MODIFIED MONOSACCHARIDE COMPOUNDS | CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (CNRS) (FR) | 2016-08-18 | — | — | US | disclosed |
| CN-105683389-A | Method for specifically labeling live bacteria comprising use of modified monosaccharide compounds | 国家科学研究中心 | 2016-06-15 | — | — | CN | disclosed |
| WO-2015063173-A1 | A METHOD FOR LABELING SPECIFICALLY LIVING BACTERIA COMPRISING THE USE OF MODIFIED MONOSACCHARIDE COMPOUNDS | CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (CNRS) (FR) | 2015-05-07 | — | — | WO | disclosed |
| EP-2868750-A1 | A method for labeling specifically living bacteria comprising the use of modified monosaccharide compounds | Centre National de la Recherche Scientifique (C.N.R.S.) (FR) | 2015-05-06 | — | — | EP | disclosed |
| US-6245902-B1 | USEFUL FOR PREPARING C-GLYCOSIDE ANALOGS OF GANGLIOSIDES, PEPTIDES, AND PROTEINS, AS WELL AS SYNTHETIC INTERMEDIATES USEFUL FOR THE PREPARATION OF THE PRECURSORS | UNIVERSITY OF IOWA RESEARCH FOUNDATION | 2001-06-12 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170204044-A1 | MULTIFUNCTIONAL (METH)ACRYLATE MANUFACTURING METHOD | MMAB, AMD1, ADH5 | TYR 1394/4885SLC5A1 4540/4885SLC5A2 4670/4885 |
| US-10619058-B2 | Curable composition | ZMYND8, AZI2, KAT2A | TYR 1051/4885SLC5A1 4736/4885SLC5A2 4744/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.